The discovery of PCC1, a substance capable of "precisely, efficiently, and safely eliminating senescent cells," is hailed as a new milestone in the anti-aging, marking an important step forward in BYHEALTH's research in the field of anti-aging.
The discovery of PCC1, a substance capable of "precisely, efficiently, and safely eliminating senescent cells," is hailed as a new milestone in the anti-aging, marking an important step forward in BYHEALTH's research in the field of anti-aging.
Leveraging health models and algorithms, we've built an industry-leading "homeostasis" assessment system for the Chinese population, marking a breakthrough in homeostasis research that enables precise health evalsuation, risk prediction and future precision nutritional interventions.
Conducted in collaboration with multiple well-known domestic universities and research institutions, the release of the world's first *large-scale study on NAD+ and aging in the Chinese population.
*As of March 31, 2022, confirmed based on search results from five major authoritative academic literature databases (CNKI, Wanfang, PubMed, Web of Science, Elsevier ScienceDirect).
Committed to creating the ultimate nutrition products with the spirit of science
We develop functional dietary supplements (NutraCeuticals) according to
rigorous scientific research and development standards
We develop functional dietary supplements (NutraCeuticals) according to rigorous scientific research and development standards
Derived from
rigorous scientific research
Scientifically
effective dose
Clearly defined
active ingredients
Efficacy
experimental validation
Following eight years of dedicated research on Fruitflow—renowned as "natural aspirin"—for maintaining normal platelet aggregation, we have completed experimental validation of its impact on blood flow health in the Chinese population. This milestone establishes BYHEALTH as the industry pioneer to submit regulatory files for new functional claim and product registration.
Independently developed the high-quality strain LPB27 derived from the gut of healthy Chinese infants, and obtained multiple Chinese invention patents.
BYHEALTH has launched its first personalized vitamin concept product, utilizing Dried Blood Spot (DBS) testing technology to precisely analyze individual variations. This enables truly individualized nutrition formulations, driving the practical implementation of precision nutrition solutions.
We hold over 400 domestic and international patents, published 68 research papers in top scientific journals, and participated in developing 50+ standards (international, national, industry, and group)*.
*Data as of March 31, 2024.
